Normal Values of High Frequency ECG (HyperQ™) in Apparently Healthy Individuals and in Young and Masters Athletes
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2010 by BSP Biological Signal Processing Ltd..
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
BSP Biological Signal Processing Ltd.
Information provided by:
BSP Biological Signal Processing Ltd.
ClinicalTrials.gov Identifier:
NCT00847353
First received: February 18, 2009
Last updated: February 3, 2010
Last verified: February 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The main objective of this study is to investigate depolarization characteristics represented by changes in HyperQ in asymptomatic, apparently healthy athletic and non-athletic individuals. We also aim to examine a subgroup of obese and non-obese subjects. The goal of the study is to establish normal HyperQ values in these populations and compare HyperQ values of age-matched athletic vs. non-athletic individuals of similar health status.
Condition |
---|
Healthy Asymptomatic Obesity |
Study Type: | Observational |
Study Design: | Time Perspective: Prospective |
Official Title: | Normal Values of High Frequency ECG (HyperQ™) in Asymptomatic, Apparently Healthy Normal Weight vs. Obese Individuals and in Young and Masters Athletes |
Resource links provided by NLM:
Further study details as provided by BSP Biological Signal Processing Ltd.:
Primary Outcome Measures:
- Normal values for depolarization characteristics will be established for study groups [ Time Frame: end of data collection ] [ Designated as safety issue: No ]
Estimated Enrollment: | 300 |
Study Start Date: | February 2009 |
Estimated Study Completion Date: | June 2010 |
Estimated Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |
Eligibility
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Study Population
community sample referred or self referred to stress testing
Criteria
Inclusion Criteria:
- An asymptomatic, apparently healthy patient performing a maximal exercise stress test
Exclusion Criteria:
- Contraindications for an exercise test
- Wolff-Parkinson-White (pre-excitation) syndrome
- Atrial Fibrillation or significant ventricular arrhythmia
- Treatment with Digoxin
- Pacemaker
- Pregnancy or suspected pregnancy
- QRS duration>120ms or other conduction delays
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00847353
Contacts
Contact: • Irena Imanuel, MD | 09-8639420 | |
Contact: Eyal Shargal, PhD | 09-8639420 | Eyal@wingate.org |
Locations
Israel | |
The Ribstein Center for Sports Medicine and Research | Recruiting |
Netanya, Israel | |
Contact: Eyal Shargal, PhD eyal@wingate.org | |
Principal Investigator: Dr Irena Imanuel, MD | |
Sub-Investigator: Rutie Pilz-Burstein, PhD |
Sponsors and Collaborators
BSP Biological Signal Processing Ltd.
More Information
No publications provided
Keywords provided by BSP Biological Signal Processing Ltd.:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on September 26, 2012
No publications provided
Responsible Party: | Prinicipal Investigator, The Ribstein Center for Sports Medicine and Research, Wingate |
ClinicalTrials.gov Identifier: | NCT00847353 History of Changes |
Other Study ID Numbers: | WIN_01 |
Study First Received: | February 18, 2009 |
Last Updated: | February 3, 2010 |
Health Authority: | Israel: Ethics Commission |
Keywords provided by BSP Biological Signal Processing Ltd.:
high frequency ECG normal values asymptomatic obese |
Additional relevant MeSH terms:
Obesity Overnutrition Nutrition Disorders |
Overweight Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on September 26, 2012